Extract not available.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
GLAXOSMITHKLINE PLC
GlaxoSmithKline plc (GSK) is currently the second-largest pharmaceutical company in the world. Its pharmaceutical segment covers anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. The company produces the popular asthma medicine Advair. GSK’s consumer healthcare segment handles products such as oral healthcare, nutritional drinks, and over the counter medicines. Founded in 1935, GSK’s headquarters are located in Uxbridge, UK.
GlaxoSmithKline plc is part of Business Exchange, suggested by
Ulli Muenker.
This topic contains
758 news
and
87 blog
items.
Read updated news, blogs, and resources about GlaxoSmithKline plc. Find user-submitted articles and reactions on GlaxoSmithKline plc from
like-minded professionals.
News
Recent news on this topic.
Last September, the Food and Drug Administration announced that it was severely restricting the use of...
Last September, the Food and Drug Administration announced that it was severely restricting the use of...
also initiated five other new but very small positions in Telefonica(TEF), Eli Lilly(LLY), Bristol Myers(BMY),...
it has taken to make children's medicines safer and easier to use. Member companies include J&J, Novartis,...
an insurer or other counterparty that promises to pay some or all of the future liabilities. Last year, GlaxoSmithKline...
million, down from ��204m in the same period a year ago. Drugmakers were weak as well, led by GlaxoSmithKline which...
Extract not available.
such as IMI , down 37p at ��10.35 after a downgrade from Exane BNP Paribas, and pharmaceuticals, with GlaxoSmithKline...
an insurer or other counterparty that promises to pay some or all of the future liabilities. Last year, GlaxoSmithKline...
an insurer or other counterparty that promises to pay some or all of the future liabilities. Last year, GlaxoSmithKline...
Nasdaq, Amgen is likely to be aided by the dominance of other drugmakers such as Eli Lilly (LLY), GlaxoSmithKline...
enforcement action" as well as pricing pressure in the EU. Its key recommendation was an underweight rating on...
makes money by selling the technology behind the scratch-offs to big pharma companies like Johnson & Johnson and...
Greece's high costs of borrowing will force it to undertake some form of debt restructuring. Elsewhere, drugmaker...
healthcare provider or other healthcare professionals for follow-up. The remembrance sponsor of the event this year is...
healthcare provider or other healthcare professionals for follow-up. The remembrance sponsor of the event this year is...
care stocks. According to 13F filings with the SEC after the closing bell Monday, Eli Lilly, AstraZeneca and...
care stocks. According to 13F filings with the SEC after the closing bell Monday, Eli Lilly, AstraZeneca and...
waiting for that. A little move and then a lot of stocks should be looking quite good. Arvind, GlaxoSmithKline Pharma...
COPD in November 2009, boosting the Swiss drugmaker's ambitions in respiratory medicine, a field currently dominated by...
COPD in November 2009, boosting the Swiss drugmaker's ambitions in respiratory medicine, a field currently dominated by...
said it has taken $2 billion in orders this year after winning contracts in Algeria, Iraq and Malaysia.
those with the highest cumulative dose of the drug. Actos is in the same class of drugs as GlaxoSmithKline's Avandia,...
to capture that market. It���s high quality and delivering an excellent growth story.��� Both Pfizer Inc.
Top Sources: GlaxoSmithKline plc
- Financial Times
- Morningstar.com
- MarketWatch
- BusinessWeek
- TheStreet.com
- Reuters UK
- Philadelphia Inquirer
- Reuters
- google.com
- online.wsj.com
account